Volume 146, Issue 1, Pages e35 (January 2014)

Slides:



Advertisements
Similar presentations
Volume 130, Issue 4, Pages (April 2006)
Advertisements

Volume 140, Issue 2, Pages e7 (February 2011)
Volume 137, Issue 3, Pages e4 (September 2009)
Volume 139, Issue 3, Pages e2 (September 2010)
Volume 137, Issue 4, Pages (October 2009)
Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome/acute myeloid leukemia by Hironori.
Volume 150, Issue 4, Pages (April 2016)
Volume 142, Issue 4, Pages e3 (April 2012)
Volume 143, Issue 3, Pages e2 (September 2012)
Volume 138, Issue 1, Pages e3 (January 2010)
Large Hepatitis Delta Antigen Modulates Transforming Growth Factor-β Signaling Cascades: Implication of Hepatitis Delta Virus–Induced Liver Fibrosis 
Volume 133, Issue 6, Pages (December 2007)
Izumi Onitsuka, Minoru Tanaka, Atsushi Miyajima  Gastroenterology 
Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
Volume 151, Issue 2, Pages e12 (August 2016)
Volume 137, Issue 4, Pages (October 2009)
Volume 137, Issue 2, Pages e2 (August 2009)
Genetic Features of Aflatoxin-Associated Hepatocellular Carcinoma
Volume 140, Issue 2, Pages e7 (February 2011)
Volume 137, Issue 2, Pages (August 2009)
Is HCV Infection a Neurologic Disorder?
EPS15R, TASP1, and PRPF3 Are Novel Disease Candidate Genes Targeted by HNF4α Splice Variants in Hepatocellular Carcinomas  Monika Niehof, Jürgen Borlak 
Covering the Cover Gastroenterology
Volume 142, Issue 3, Pages (March 2012)
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Volume 139, Issue 6, Pages (December 2010)
Volume 142, Issue 3, Pages (March 2012)
Volume 138, Issue 2, Pages (February 2010)
Volume 140, Issue 1, Pages e2 (January 2011)
Volume 131, Issue 4, Pages (October 2006)
Volume 140, Issue 2, Pages e7 (February 2011)
Volume 140, Issue 1, Pages (January 2011)
Volume 138, Issue 1, Pages e3 (January 2010)
Volume 137, Issue 3, Pages e4 (September 2009)
Volume 136, Issue 2, Pages (February 2009)
Toll-Like Receptor 5 Engagement Modulates Tumor Development and Growth in a Mouse Xenograft Model of Human Colon Cancer  Sang Hoon Rhee, Eunok Im, Charalabos.
Laminin γ2 Mediates Wnt5a-Induced Invasion of Gastric Cancer Cells
Volume 133, Issue 3, Pages (September 2007)
Volume 141, Issue 4, Pages e2 (October 2011)
Volume 135, Issue 1, Pages (July 2008)
Volume 132, Issue 4, Pages (April 2007)
Volume 142, Issue 7, Pages e3 (June 2012)
Volume 137, Issue 4, Pages (October 2009)
Volume 138, Issue 5, Pages e2 (May 2010)
Volume 127, Issue 3, Pages (September 2004)
Volume 139, Issue 1, Pages e6 (July 2010)
Volume 29, Issue 4, Pages (April 2016)
Volume 141, Issue 6, Pages e5 (December 2011)
Volume 150, Issue 4, Pages (April 2016)
Volume 140, Issue 3, Pages (March 2011)
Volume 141, Issue 1, Pages e4 (July 2011)
Volume 142, Issue 6, Pages e3 (May 2012)
Volume 130, Issue 4, Pages (April 2006)
Volume 132, Issue 3, Pages (March 2007)
Daniel F. Wallace, Lesa Summerville, V. Nathan Subramaniam 
Volume 142, Issue 7, Pages e2 (June 2012)
Volume 136, Issue 2, Pages e3 (February 2009)
Volume 135, Issue 3, Pages e3 (September 2008)
Volume 130, Issue 4, Pages (April 2006)
Volume 134, Issue 4, Pages (April 2008)
Volume 145, Issue 3, Pages e11 (September 2013)
Volume 134, Issue 1, Pages (January 2008)
Volume 133, Issue 3, Pages (September 2007)
Volume 138, Issue 3, Pages e3 (March 2010)
Volume 132, Issue 4, Pages (April 2007)
Volume 140, Issue 5, Pages e2 (May 2011)
Volume 139, Issue 1, Pages e2 (July 2010)
Volume 137, Issue 4, Pages (October 2009)
Volume 138, Issue 2, Pages e6 (February 2010)
Volume 139, Issue 3, Pages e2 (September 2010)
Presentation transcript:

Volume 146, Issue 1, Pages 222-232.e35 (January 2014) Leptin Receptor Somatic Mutations Are Frequent in HCV-Infected Cirrhotic Liver and Associated With Hepatocellular Carcinoma  Atsuyuki Ikeda, Takahiro Shimizu, Yuko Matsumoto, Yosuke Fujii, Yuji Eso, Tadashi Inuzuka, Aya Mizuguchi, Kazuharu Shimizu, Etsuro Hatano, Shinji Uemoto, Tsutomu Chiba, Hiroyuki Marusawa  Gastroenterology  Volume 146, Issue 1, Pages 222-232.e35 (January 2014) DOI: 10.1053/j.gastro.2013.09.025 Copyright © 2014 AGA Institute Terms and Conditions

Figure 1 Schematic diagram showing the number of mutated genes in tumors and the number of genes commonly mutated in both tumor and the matched nontumorous liver tissues. Patients 1, 2, and 3 had synchronously developed HCCs, and patient 4 had a solitary HCC. Venn diagrams represent the number of mutated genes in each HCC tissue determined by whole exome sequencing. The numbers of genes commonly mutated in the synchronously developed multiple HCCs were 32, 9, and 0 in patients 1, 2, and 3, respectively. Among the mutated genes in HCC (at a frequency of more than 20% of reads), the number of genes commonly mutated in both HCC and matched nontumorous background liver (at a frequency of more than 5% of reads) is shown in shaded circles. Gastroenterology 2014 146, 222-232.e35DOI: (10.1053/j.gastro.2013.09.025) Copyright © 2014 AGA Institute Terms and Conditions

Figure 2 The number of mutated genes and the distribution of mutation frequency in tumor and nontumorous cirrhotic liver tissues. The number of mutated genes (upper panel) and the distribution of mutation frequency (lower panel) detected by whole exome sequencing in each sample are shown (at a frequency of more than 20% of reads). Patients 1, 2, and 4 had more mutated genes in nontumorous liver tissue than those in HCC, while the mutation frequency at each nucleotide position in the majority of nontumorous cirrhotic liver tissues was <30%. NT, nontumorous cirrhotic liver. Gastroenterology 2014 146, 222-232.e35DOI: (10.1053/j.gastro.2013.09.025) Copyright © 2014 AGA Institute Terms and Conditions

Figure 3 Distribution of mutations in the LEPR sequence in HCV-positive cirrhotic liver tissues. (A) Schematic diagram of the LEPR gene (top panel) and the Ig domain (middle panel). Mutated positions in the Ig domain are indicated by black triangles. A total of 38 of 67 (56.7%) mutated nucleotide positions of the Ig domain were recurrently mutated in 2 or more HCV-positive cirrhotic liver tissues. Frequencies of nonsynonymous (black circles) and synonymous (gray diamonds) mutations at each nucleotide position of the Ig domain of each sample are shown (lower panel). Nonsynonymous mutations were detected at 62 of the 67 nucleotide positions. (B and C) HEK293 cells were transfected with constructs encoding wild-type or representative various mutated LEPRs that were identified in HCV-positive cirrhotic liver tissues. Control: empty vector. (B) Immunoblotting was performed on the lysate of the cells expressing either wild-type or a mutated Ig domain (D332Y, V333A, Y426X, and V427M) of the LEPR gene using anti-Myc antibodies. (C) After transfection, the cells were treated with or without recombinant leptin protein. Total protein was isolated and immunoblot analysis was performed using anti–phospho-STAT3 (upper panel) and anti–total STAT3 (lower panel). Gastroenterology 2014 146, 222-232.e35DOI: (10.1053/j.gastro.2013.09.025) Copyright © 2014 AGA Institute Terms and Conditions

Figure 4 Tumors developed in db/db mice treated with TAA. (A) Representative macroscopic (left panel) and microscopic (right panel) images (H&E stain) of the liver from a db/db mouse and a littermate control mouse without administration of TAA. The liver of the db/db mouse is enlarged and yellowish compared with the control (yellow arrowheads). Histological analysis of the liver tissue of (ii and iv) db/db mouse and (i and iii) control mouse. Original magnification: 4× (upper panels) and 10× (lower panels). (B) Microscopic images (H&E stain) of (i and iii) control mice and (ii and iv) db/db mice treated with TAA for 24 weeks. In the db/db mice, inflammatory cell infiltration was extensively observed in the liver tissues underlying prominent steatosis (ii and iv). Original magnification: 4× (upper panels) and 20× (lower panels). (C) Microscopic images (H&E stain) of nodules that developed in db/db mice treated with TAA for 24 weeks (i–vi). Liver cancers developed in 2 db/db mice (i–iv). Arrowheads indicate hepatocyte hyperplasia (v and vi). Original magnification: 4× (left panels) and 10× (right panels). Gastroenterology 2014 146, 222-232.e35DOI: (10.1053/j.gastro.2013.09.025) Copyright © 2014 AGA Institute Terms and Conditions

Supplementary Figure 1 Gastroenterology 2014 146, 222-232.e35DOI: (10.1053/j.gastro.2013.09.025) Copyright © 2014 AGA Institute Terms and Conditions

Supplementary Figure 2 Gastroenterology 2014 146, 222-232.e35DOI: (10.1053/j.gastro.2013.09.025) Copyright © 2014 AGA Institute Terms and Conditions

Supplementary Figure 3 Gastroenterology 2014 146, 222-232.e35DOI: (10.1053/j.gastro.2013.09.025) Copyright © 2014 AGA Institute Terms and Conditions

Supplementary Figure 4 Gastroenterology 2014 146, 222-232.e35DOI: (10.1053/j.gastro.2013.09.025) Copyright © 2014 AGA Institute Terms and Conditions

Supplementary Figure 5 Gastroenterology 2014 146, 222-232.e35DOI: (10.1053/j.gastro.2013.09.025) Copyright © 2014 AGA Institute Terms and Conditions

Supplementary Figure 6 Gastroenterology 2014 146, 222-232.e35DOI: (10.1053/j.gastro.2013.09.025) Copyright © 2014 AGA Institute Terms and Conditions